Madrigal Pharmaceuticals, Inc.
MDGL
$421.90
$9.672.35%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -24.65% | -20.39% | 46.07% | 329.79% | 254.47% |
| Total Receivables | 1,048.44% | -- | -- | -- | -- |
| Inventory | 797.86% | 6,368.50% | -- | -- | -- |
| Prepaid Expenses | 291.66% | 65.60% | 337.65% | 569.05% | 370.98% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | -- | -- | -- | -- |
| Total Current Assets | -8.09% | -8.01% | 62.08% | 351.72% | 261.98% |
|
|
|||||
| Total Current Assets | -8.09% | -8.01% | 62.08% | 351.72% | 261.98% |
| Net Property, Plant & Equipment | 137.29% | 20.52% | 40.57% | 91.58% | 263.86% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -7.37% | -7.22% | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -7.67% | -7.91% | 62.71% | 351.02% | 263.61% |
|
|
|||||
| Total Accounts Payable | 322.23% | 95.35% | 55.48% | 177.87% | -48.71% |
| Total Accrued Expenses | 36.21% | 34.57% | 38.58% | 58.58% | 41.40% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 88.33% | 87.45% | 86.53% | 71.15% | 35.52% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 57.00% | 46.26% | 42.79% | 78.44% | 25.53% |
|
|
|||||
| Total Current Liabilities | 57.00% | 46.26% | 42.79% | 78.44% | 25.53% |
| Long-Term Debt | 1.52% | 1.61% | 1.81% | 2.06% | 17.49% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 402.67% | -28.23% | -14.17% | -11.11% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 31.62% | 23.53% | 22.38% | 37.27% | 21.97% |
|
|
|||||
| Common Stock & APIC | 4.78% | 10.75% | 46.80% | 102.08% | 102.88% |
| Retained Earnings | -17.23% | -26.39% | -34.86% | -42.37% | -45.36% |
| Treasury Stock & Other | 401.90% | 326.16% | 0.00% | 3,126.19% | -313.48% |
| Total Common Equity | -18.80% | -16.47% | 86.11% | 3,392.99% | 728.09% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -18.80% | -16.47% | 86.11% | 3,392.99% | 728.09% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -18.80% | -16.47% | 86.11% | 3,392.99% | 728.09% |
|
|
|||||